Mid-infrared Wearable for Non-invasive biomarker monitoring
The project aims to develop a wearable device using a miniature Mid-Infrared spectrometer for non-invasive biomarker detection in metabolic syndrome, enhancing early diagnosis and management.
Projectdetails
Introduction
Modern medicine has improved dramatically through a better understanding of what causes a condition or what it is correlated to. However, the healthcare system still follows an episodic (reactive) model, where patients only seek medical advice when there are symptoms. This approach has proven critically insufficient for certain medical conditions.
Background
In this context, one of the main burdens for our socioeconomic system in Europe caused by a single disease is undoubtedly the metabolic syndrome (MbS). MbS is prominently visible in the large and ever-growing number of overweight or obese individuals.
Consequences of Metabolic Syndrome
The true negative dramatic consequences of MbS include:
- Arteriosclerosis
- Myocardial infarction
- Stroke
Several biomarkers such as uric acid, albumin, or ketone bodies correlate with MbS and often indicate different aspects of the metabolic syndrome. The more biomarkers that can be measured and quantified with high accuracy, the easier it becomes to make conclusive decisions on the patient’s status.
Importance of Accurate Measurements
False negatives as well as false positives can be avoided much better with more parameters. This is achievable if each of them is measured individually and directly, without the need for indirect methods where evaluations are easily overfitted.
Proposed Solution
We provide an alternative approach for the measurement of biomarkers, using a miniaturized Mid-Infrared spectrometer, a technology that is currently only used in laboratories due to its size and cost. The result of the project will be a wearable device to detect biomarkers non-invasively and pain-free in the interstitial fluid in the skin.
Consortium and Engagement
For MiWear, we have gathered an impressive consortium combining expert knowledge in:
- Biomarkers
- Optical spectroscopy
- Laser physics
- Business management
- Finances
- The gender dimension of biomarkers
During the project, we will generate opportunities for young researchers and engage with different stakeholders to ensure maximum outreach of our research and development activities.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 3.991.297 |
Totale projectbegroting | € 3.991.297 |
Tijdlijn
Startdatum | 1-1-2024 |
Einddatum | 31-12-2026 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- QUANTUNE TECHNOLOGIES GMBHpenvoerder
- JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH
- STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
- TEKNOLOGIAN TUTKIMUSKESKUS VTT OY
- ARTIFICIAL INTELLIGENCE EXPERT SRL
- SCIENCE&STRATEGY SL
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Speckle Technology and Digital Biomarkers of Microvascular Function for Monitoring Cardiovascular DiseasesThe project aims to develop innovative monitoring instruments for early detection of cardiovascular diseases, integrating advanced technologies to reduce healthcare burdens and costs in the EU. | EIC Pathfinder | € 3.979.006 | 2023 | Details |
In-vessel implantable smart sensing device for personalised medicineThe IV-Lab project develops a miniaturized implantable sensor for continuous health monitoring in cardiovascular patients, enabling personalized medical interventions and reducing hospitalizations. | EIC Pathfinder | € 4.158.610 | 2023 | Details |
Multivariate optoacoustic sensor for longitudinal diabetes monitoringMOSAIC aims to develop a portable, non-invasive optoacoustic sensor powered by explainable AI to monitor diabetes, enhancing early detection and treatment while reducing healthcare costs. | EIC Pathfinder | € 2.997.921 | 2025 | Details |
Kidney Disease Sweat sensor patch for Early diagnosis and Remote MonIToringThe KERMIT project aims to develop a cost-effective, disposable sweat patch for non-invasive early detection and remote monitoring of chronic kidney disease biomarkers. | EIC Pathfinder | € 3.080.623 | 2023 | Details |
Unobtrusive Continuous Multi-Metabolite Monitoring for a Physiological Care of Insulin-treated DiabetesThis project aims to revolutionize diabetes management through a fully implantable multi-metabolite monitoring system and automated insulin delivery, enhancing metabolic health and reducing complications. | EIC Pathfinder | € 3.885.462 | 2023 | Details |
Speckle Technology and Digital Biomarkers of Microvascular Function for Monitoring Cardiovascular Diseases
The project aims to develop innovative monitoring instruments for early detection of cardiovascular diseases, integrating advanced technologies to reduce healthcare burdens and costs in the EU.
In-vessel implantable smart sensing device for personalised medicine
The IV-Lab project develops a miniaturized implantable sensor for continuous health monitoring in cardiovascular patients, enabling personalized medical interventions and reducing hospitalizations.
Multivariate optoacoustic sensor for longitudinal diabetes monitoring
MOSAIC aims to develop a portable, non-invasive optoacoustic sensor powered by explainable AI to monitor diabetes, enhancing early detection and treatment while reducing healthcare costs.
Kidney Disease Sweat sensor patch for Early diagnosis and Remote MonIToring
The KERMIT project aims to develop a cost-effective, disposable sweat patch for non-invasive early detection and remote monitoring of chronic kidney disease biomarkers.
Unobtrusive Continuous Multi-Metabolite Monitoring for a Physiological Care of Insulin-treated Diabetes
This project aims to revolutionize diabetes management through a fully implantable multi-metabolite monitoring system and automated insulin delivery, enhancing metabolic health and reducing complications.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Miniaturized flexible batteries for next generation wearable healthcare sensorsFlexiMin aims to develop a flexible, miniaturized battery to power next-gen wearable sensors for continuous biomarker monitoring, enhancing healthcare diagnostics and market readiness. | ERC Proof of... | € 150.000 | 2025 | Details |
Accurater metabolisme meetinstrumentHet project ontwikkelt een modulair ademgasanalysesysteem voor (top)sport en medische diagnostiek, gericht op het meten van energieverbruik en -balans met minimale belasting voor gebruikers. | Mkb-innovati... | € 103.748 | 2016 | Details |
Fast and simple biomarker detection by computational microscopyWe developed a fast, sensitive biomarker detection method for early diagnosis and monitoring of cancer treatments, aiming to improve patient outcomes through preventative diagnostics. | ERC Proof of... | € 150.000 | 2024 | Details |
Ontwikkeling textielgebaseerde biosensor om biomarkers in zweet te monitorenParamedir B.V. onderzoekt de haalbaarheid van elektrochemische biosensoren voor continue monitoring van biomarkers in zweet in textiel, met als doel betrouwbare gegevens voor gezondheidsmonitoring te leveren. | Mkb-innovati... | € 20.000 | 2022 | Details |
Geautomatiseerde bloeddrukmetingHet project onderzoekt de haalbaarheid van continue bloeddrukmeting met innovatieve technologieën voor betere cardiovasculaire zorg. | Mkb-innovati... | € 20.000 | 2022 | Details |
Miniaturized flexible batteries for next generation wearable healthcare sensors
FlexiMin aims to develop a flexible, miniaturized battery to power next-gen wearable sensors for continuous biomarker monitoring, enhancing healthcare diagnostics and market readiness.
Accurater metabolisme meetinstrument
Het project ontwikkelt een modulair ademgasanalysesysteem voor (top)sport en medische diagnostiek, gericht op het meten van energieverbruik en -balans met minimale belasting voor gebruikers.
Fast and simple biomarker detection by computational microscopy
We developed a fast, sensitive biomarker detection method for early diagnosis and monitoring of cancer treatments, aiming to improve patient outcomes through preventative diagnostics.
Ontwikkeling textielgebaseerde biosensor om biomarkers in zweet te monitoren
Paramedir B.V. onderzoekt de haalbaarheid van elektrochemische biosensoren voor continue monitoring van biomarkers in zweet in textiel, met als doel betrouwbare gegevens voor gezondheidsmonitoring te leveren.
Geautomatiseerde bloeddrukmeting
Het project onderzoekt de haalbaarheid van continue bloeddrukmeting met innovatieve technologieën voor betere cardiovasculaire zorg.